Meet your Virtual Organising Committee

The BSPR Interact 2021 virtual organising committee (VOC) comprises of members of the BSPR management committee and board of directors. Meet the team below!

Maike Langini

BSPR Interact 2021 VOC Chair 

BSPR Management Committee Member

Currently, Maike is working at Medicines Discovery Catapult on a collaborative study with LifeArc focused on applying mass spectrometry-based proteomics in the field of drug discovery. She is finishing her PhD in chemistry at the Heinrich Heine University Düsseldorf with Prof Kai Stühler. Previous research focused on lncRNA based perturbations of protein signatures in brain tumours, secretome analysis in cancer cell lines and tumour tissue proteomics and phospho-proteomics.

Since 2017, Maike has been working with the Young Proteomics Investigators Club (YPIC), the early career researcher group off EuPA, and was elected as their president in 2020. She joined the BSPR management committee in 2019 as YPIC representative.


Kathryn Lilley

BSPR Interact 2021 Scientific Programme

BSPR Management Committee Member

Kathryn received her PhD in Biochemistry from the University of Sheffield in 1990. After being a laboratory manager at the University of Leicester for eleven years, she established the Cambridge Center for Proteomics, University of Cambridge in 2000. She became the Professor in Cellular Dynamics in Department of Biochemistry University of Cambridge in 2012.

Her research programme aims to create technology to measure the dynamics of the proteome and transcriptome in high throughput in space and time during critical cellular processes. Her group has also contributed many open-source informatics tools to efficiently mine and visualise complex data which is produced by spatiotemporal proteomics studies.

She is a recipient of a Wellcome Trust Investigator Award to investigate the role the site of translation plays on the control of protein intracellular.

She is also a partner in EPIC-XS, funded as part of the Horizon 2020 Work programme to develop and provide proteomics technologies across Europe. She has also attracted considerable funding from industry.

Her research group is comprised of 20 postdoctoral researchers and PhD students.

She has published more than 250 peer reviewed papers. In 2017 she was the recipient of the Juan Pablo Albar Proteome Pioneer Award from the European Proteomics Association and in 2018 received the HUPO Distinguished Achievements in Proteomics award. She was elected as a member of EMBO in July 2020.


James Waddington

BSPR Interact 2021 Website & Promotion 

BSPR Management Committee Member

 James obtained his PhD in Molecular and Clinical Pharmacology from the University of Liverpool in 2019 under the supervision of Prof Kevin Park, Dr Xiaoli Meng and Prof Dean Naisbitt. Previous research focuses included the implementation of novel techniques to analyse microbial metagenomics signatures in order to identify disease biomarkers, and cellular responses to HIV viral infection. More recently James focussed on the characterisation of naturally processed MHC peptides that act as T-cell antigens in patients with drug hypersensitivity. 

​James joined Prof Steve Pennington's group as a post doctoral research fellow at University College Dublin in 2020, working on the European Horizon 2020 funded SCREENED project. In addition to his academic role, James also joined the Atturos team in 2020 where he is actively involved in product development and the management of laboratory based strategic research agreements.


During his PhD, James was the student representative for the BSPR. Since completing his degree James has continued to work closely with the BSPR, joining the management committee as a full member. James has also worked with HUPO on the generation of the HUPO Proteomics Timeline to coincide with the release of the HUPO HPP Decadal Blueprint, and is currently the HUPO Marketing Committee Co-Chair. 

Sara Zanivan

BSPR Interact 2021 Scientific Programme

BSPR Board of Directors Member

Sara leads the Tumour Microenvironment & Proteomics lab and is head of the Proteomics Advanced Technology Facility at the CRUK Beatson Institute in Glasgow. In 2019, she became Professor of Tumour Stroma Biology at the University of Glasgow. She studied biology at the University of Torino (Italy) and she obtained her PhD degree at the Candiolo Cancer Institute (Italy). Before obtaining her current position at the Beatson she joined Matthias Mann group at the Max-Planck Institute of Biochemistry (Germany) as a post-doctoral fellow.

The research of Sara’s team focuses on better understanding the biology of the tumour stromal cells cancer-associated fibroblasts (CAFs), with the overarching goal to determine ways to target CAFs for therapy. Sara’s team has contributed to discover new molecular mechanisms that underpin pro-tumorigenic and pro-invasive functions of CAFs in breast and ovarian cancer. They achieved this by using in vitro and in vivo tumour models, and developing MS-proteomics technologies, particularly aimed at the study of cell secretome and cysteine modifications for global redox signalling analysis.

For more information, see or follow us on Twitter @szanivan


Harry Whitwell 

BSPR Interact 2021 Co-Treasurer & Sponsor Liaison

BSPR Board of Directors Member

In 2016, Harry Whitwell completed his PhD from the University of Southampton with Dr Jens Madsen, Prof Howard Clark and Dr Paul Skipp, investigating the effect of nanoparticles on pulmonary surfactant and epithelium. After starting his post-doc in 2015 with Dr John Timms, he worked on several approaches to develop longitudinal and network-based (parenclitic) biomarker models from serological proteins.


In 2017, he moved to Imperial College London, to develop methods for identifying methyltransferase-substrates. In 2020, he took a position with Dr Matthew Lewis, Prof Jules Griffin and Prof Zoltan Takats as Proteomics Lead, jointly in the National Phenome Centre and the Division of Systems Medicine at Imperial College London, where he is implementing proteomics technologies while undertaking his research into the role of protein methylation in cancer.


As well as being on the organisational committee for BSPR, Harry is also a founding member of the London Proteomics Discussion Group (LPDG).


For more information, see

Whitwell_Harry (1).png

Phil Green

BSPR Interact 2021 Co-Treasurer & Sponsor Liaison

BSPR Management Committee Member 

Currently Phil is Sales Manager for Life Science Mass Spectrometry at Thermo Fisher Scientific covering UK, Ireland and Nordic regions. Prior to Joining Thermo Fisher Scientific Phil spend 10-years in industry as a protein mass spectrometry specialist. Phil has a PhD in biological mass spectrometry from University of Warwick.


Kareena Adair

BSPR Interact 2021 Media & Communications

BSPR Management Committee Member (Student Representative)

Kareena is a final year PhD student and Research Technician in Clinical and Molecular Pharmacology at the University of Liverpool, under the supervision of Professor Dean Naisbitt and Dr Xiaoli Meng. Current research focuses on investigating the immunogenicity of drug-protein adducts and the role of MHC in drug-induced hypersensitivity reactions.


“Throughout my PhD I have developed skills in a range of proteomic techniques including HPLC and mass spectrometry. Upon completion of my PhD in 2021, I hope to continue working within the proteomics field in a post-doctoral position”

As the Student Representative, Kareena works closely with the management committee as a voice for the student members of the BSPR.


Stephen Pennington

BSPR Interact 2021 VOC Advisor

BSPR President

Steve Pennington is a Professor of Proteomics in UCD and founder and CSO of Atturos Ltd. A chemist (Imperial College, London) and Ph.D. biochemist (University of Cambridge) by training, Steve has spent much of his research career using mass spectrometry to measure and characterise proteins, developing significant insights into the molecular diagnostics arena through the identification of novel biomarkers of disease.


To date, Steve has given over 250 invited presentations at international events, published over 95 scientific papers as well as editing and contributing to several books, including editing one of the first books on Proteomics that was translated into Chinese and Japanese.


Steve was awarded an Elmore Medical Research Fellowship while in Cambridge and subsequently was the recipient of a Sir Henry Wellcome Award for Innovative Research and more recently (in 2018) received NovaUCD Innovator of the year. He has filed multiple patents and is currently the BSPR President and Outgoing President of the Human Proteome Organisation.

Pennington_Steve (1).png